Bayer to Invest More Than €500 Million in Haemophilia Pipeline

12.03.2014 - BayerHealthcare plans to invest more than €500 million at its sites in Wuppertal and Leverkusen, Germany, to expand capacity for production of its recombinant factor VIII...